Stocks / Pharmaceuticals
Johnson & Johnson Stock Falters as Cancer Therapy Gets Warning Label
Johnson & Johnson (JNJ) stock is trending lower following an FDA warning label for its Carvykti cancer therapy, even as the company prepares to release its Q3 earnings report. The FDA sanctioned a warning label to be added to Carvykti, a ce...